News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cellerant Therapeutics, Inc. Appoints Gisela Schwab, M.D., to Its Board of Directors and Names Lowell Sears as Chairman of the Board



6/15/2012 10:06:24 AM

SAN CARLOS, Calif.--(BUSINESS WIRE)--Cellerant Therapeutics Inc., a biotechnology company developing novel hematopoietic stem cell-based cellular and antibody therapies for blood disorders and cancer, announced today the appointment of Gisela Schwab, M.D. to its Board of Directors and the appointment of Lowell Sears as Chairman of the Board. Richard Rathmann, Cellerant’s former Chairman of the Board, will remain a director on the Board.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES